NCT03735095View on ClinicalTrials.gov

Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

February 12, 2020

Primary Completion Date

July 26, 2024

Study Completion Date

July 26, 2024

Conditions
Locally Advanced Lung CarcinomaNon-Small Cell Lung CarcinomaSmall Cell Lung CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Solid Tumor
Interventions
DRUG

Porfimer Sodium

Given IV

PROCEDURE

Ultrasound-Guided Transbronchial Needle-Delivered Interstitial Photodynamic Therapy

Undergo EBUS-TBN guided I-PDT

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

Sponsors

Collaborators (1)

Pinnacle Biologics Inc.
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Pinnacle Biologics Inc.

INDUSTRY

collaborator

Simphotek Inc.

UNKNOWN

lead

Roswell Park Cancer Institute

OTHER

NCT03735095 - Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer | Biotech Hunter | Biotech Hunter